Indoco Remedies Limited (INDOCO) — Announcement Announcement
📢 Key Event
Indoco Remedies completes transfer of Ophthalmic Division to Sunways (India) Private Limited.
💡 Investor Takeaway
The sale removes a non-core segment, potentially improving focus and valuation for remaining businesses.
Indoco Remedies announced completion of its slump sale of the Ophthalmic Division to Sunways (India) Private Limited, finalizing a transaction approved on April 30, 2026, which removes the non-core business from its balance sheet and streamlines focus on core operations.
📄 View Original Announcement (PDF)
About Indoco Remedies Limited (INDOCO)
Healthcare · Pharmaceuticals & Biotechnology · Listed on NSE
Market Cap: ₹2,075.91 Cr
P/E: -142.3
Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.